Kodak's $765M Federal Loan Disclosure For Drug Venture Under SEC Investigation: WSJ
Eastman Kodak Company (NYSE: KODK) is under investigation by the United States Securities and Exchange Commission surrounding the announcement of a $765 million federal loan for its foray into pharmaceuticals last month, the Wall Street Journal
